{"id":"W2949791399","doi":"10.1186/s12885-019-5805-z","title":"A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA)","year":2019,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"McMaster University; Movember Foundation; Commonwealth Foundation; Astellas Pharma; Astellas Pharma US; National Cancer Institute; National Institutes of Health; Astellas Foundation for Research on Metabolic Disorders; Prostate Cancer Foundation","keywords":"Enzalutamide; Medicine; Prostate cancer; Placebo; Prostatectomy; Androgen deprivation therapy; Urology; Clinical endpoint; Internal medicine; Radiation therapy; Randomized controlled trial; Oncology; Cancer; Androgen receptor; Pathology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001268656,0.0007772575,0.002620694,0.0004966223,0.0002309536,0.00008849424,0.0002546329,0.0002214683,0.00115083],"category_scores_gemma":[0.00008470854,0.0004829358,0.0004170711,0.0007094728,0.0003827089,0.0003093577,0.0001079597,0.0007502547,0.00002661909],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001746856,"about_ca_system_score_gemma":0.003426341,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004430751,"about_ca_topic_score_gemma":0.001974304,"domain_scores_codex":[0.9945414,0.0006717933,0.001099537,0.001115369,0.001585776,0.0009860944],"domain_scores_gemma":[0.9968358,0.0007093092,0.0007768688,0.0007731401,0.000473576,0.0004313096],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9646372,0.003106118,0.009466373,0.0003358008,0.003665996,0.00007169459,0.007970809,0.001406187,0.0006031707,0.00001127118,0.0002523271,0.008473082],"study_design_scores_gemma":[0.9722862,0.01362894,0.00107831,0.0004884666,0.001728489,0.000005036094,0.0008059538,0.00296805,0.005604497,0.000008995206,0.000836812,0.0005602825],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9452064,0.01585612,0.00003851684,0.0003151336,0.001053153,0.03695679,0.0002329961,0.0001321361,0.0002087583],"genre_scores_gemma":[0.96293,0.005553503,0.0001175141,0.00007205574,0.0004305076,0.02735215,0.0001382137,0.0001421687,0.003263895],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01772359,"threshold_uncertainty_score":0.9997622,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03173270078123806,"score_gpt":0.3531103047933086,"score_spread":0.3213776040120705,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}